Medicinal Chemicals & Botanical Products · DE · CIK 1386570
Niagen Bioscience, Inc. develops and commercializes NAD+ precursors for healthy aging
Comparable business profile · signals at a glance
In the 90 days to Nov 14, 2025: 1 insider bought $46K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 2025 | Pamir OzanChief Financial Officer | Buy | 4,465 | $6.81 | $30K |
| Nov 14, 2025 | Pamir OzanChief Financial Officer | Buy | 2,220 | $6.85 | $15K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.